Eicosapentaenoic free fatty acid to treat patients with SARS-Cov2 infection

Med Hypotheses. 2020 Oct:143:110095. doi: 10.1016/j.mehy.2020.110095. Epub 2020 Jul 12.

Authors

Andrea Belluzzi¹, Eleonora Scaioli², Luigi Ricciardiello², Giovanni Marasco², Carlotta Belluzzi³

Affiliations

¹ Department of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy. Electronic address: andrea.belluzzi@aosp.bo.it.
² Department of Medical and Surgical Sciences, St. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
³ Downing College, University of Cambridge, Cambridge, United Kingdom.

PMID: 32679430
DOI: 10.1016/j.mehy.2020.110095

No abstract available

Publication types

Letter

MeSH terms

COVID-19*
Fatty Acids, Nonesterified*
Humans
RNA, Viral
SARS-CoV-2
Triglycerides

Substances

Fatty Acids, Nonesterified
RNA, Viral
Triglycerides